Seelos Therapeutics Inc. (SEEL)
0.37
-0.17 (-31.49%)
At close: Nov 18, 2024, 8:58 PM
Seelos Therapeutics Income Statement
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | FY11 | FY10 | FY09 | FY08 | FY07 | FY06 | FY05 | FY04 | FY03 | FY02 | FY01 | FY00 | FY99 | FY98 | FY97 |
| Revenue | 2.2M | n/a | n/a | n/a | 375K | n/a | n/a | 5.76M | 4.84M | 9.26M | 2.51M | 8.42M | 4.1M | 4.97M | 2.97M | 5.96M | 1.27M | 1.87M | 2.4M | 359.37K | 110.74K | 148.03K | 68.09K | 1.00 | 1.5M | 5.71M | 56.17K |
| Cost of Revenue | 57K | 53K | n/a | n/a | 22.56M | n/a | 117K | 3.89M | 922K | 918K | 2.63M | 4.55M | 2.24M | 3.94M | 128.35K | n/a | n/a | n/a | n/a | n/a | n/a | 27.03K | 45.05K | -257.15K | 1.3M | 5.19M | n/a |
| Gross Profit | 2.15M | -53K | n/a | n/a | -22.19M | n/a | -117K | 1.87M | 3.92M | 8.34M | -120K | 3.86M | 1.86M | 1.03M | 2.85M | 5.96M | 1.27M | 1.87M | 2.4M | 359.37K | 110.74K | 121K | 23.04K | 257.15K | 200K | 522.77K | 56.17K |
| Operating Income | -40.5M | -70.92M | -61.67M | -18.76M | -29.75M | -9.15M | -10.68M | -13.41M | -21.35M | -22.56M | -17.37M | -24.89M | -18.18M | -21.4M | -3.82M | -5.17M | -9.39M | -9.13M | -15.7M | -17.3M | -14.23M | -27.56M | -17.2M | -10.1M | -4.1M | -4.41M | -3.85M |
| Interest Income | 198K | 121K | 113K | 45K | 151K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 13.73K | 28.02K | 25.29K | 71.79K | 275.51K | 271.73K | 122.07K | 85K | 75.57K | 141.27K | 1.24M | 1.26M | n/a | 15.88K | n/a |
| Pretax Income | -37.88M | -73.53M | -66.05M | -19.1M | -50.88M | -9.22M | -11.75M | -7.43M | -19.02M | -22.48M | -15.87M | -25.04M | -18.12M | -29.51M | -32.48M | -6.11M | -9.59M | -8.61M | -15.92M | -17.56M | -17.47M | -27.88M | -17.38M | -9.98M | -2.3M | n/a | n/a |
| Net Income | -37.88M | -76.14M | -67.53M | -19.22M | -50.38M | -9.24M | 321K | -7.43M | -19.02M | -21.79M | -16.94M | -31.77M | -18.12M | -29.51M | -32.04M | -5.17M | -8.79M | -8.04M | -15.44M | -17.02M | -17.23M | -27.64M | -16.17M | -8.83M | -2.5M | -4.78M | -3.86M |
| Selling & General & Admin | 12.53M | 12.3M | 15.02M | 7.78M | 7.56M | 7.93M | 7.21M | 8.43M | 10.52M | 11.42M | 13.55M | 15.38M | 11.46M | 10.15M | 4.2M | 5.72M | 5.63M | 5.57M | 6.88M | 6.98M | 5.9M | 6.07M | 4.77M | 3.21M | 1.8M | 2.64M | 1.82M |
| Research & Development | 30.12M | 58.62M | 46.65M | 10.98M | 22.56M | 1.22M | 3.46M | 6.83M | 14.65M | 21.29M | 5.12M | 5.38M | 5.82M | 2.11M | 1.88M | 5.41M | 5.02M | 5.43M | 11.22M | 10.68M | 8.44M | 21.62M | 12.46M | 6.89M | 2.4M | 2.3M | 2.08M |
| Other Expenses | -30.12M | -3.02M | 230K | n/a | -375K | 1K | 77K | -22K | -64K | 82K | -376K | 175K | 2.76M | 10.17M | 457.02M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 257.15K | 100K | n/a | n/a |
| Operating Expenses | 12.59M | 70.92M | 61.67M | 18.76M | 29.75M | 9.15M | 10.67M | 15.27M | 25.16M | 30.9M | 18.68M | 20.75M | 20.04M | 22.43M | 6.08M | 11.13M | 10.66M | 11M | 18.1M | 17.66M | 14.34M | 27.68M | 17.23M | 10.36M | 4.3M | 4.94M | 3.9M |
| Interest Expense | 75K | 14K | 1.6M | 164K | 29K | n/a | 83K | 1.02M | 845K | 339K | 727K | 325K | 376.92K | 8.85M | 28.7M | 1.01M | 481.86K | 380.86K | 344.35K | 425.13K | 3.16M | 384.29K | 33.55K | n/a | n/a | 616.22K | n/a |
| Selling & Marketing Expenses | -57K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Cost & Expenses | 42.7M | 70.92M | 61.67M | 18.76M | 29.75M | 9.15M | 10.67M | 19.16M | 26.09M | 31.82M | 21.31M | 25.31M | 22.28M | 26.37M | 6.21M | 11.13M | 10.66M | 11M | 18.1M | 17.66M | 14.34M | 27.71M | 17.27M | 10.1M | 5.6M | 10.12M | 3.9M |
| Income Tax | n/a | 2.6M | 1.49M | 119K | -497K | -70K | -11.91M | 1M | 781K | -691K | 1.07M | 516K | 376.92K | 18.03M | -437.79K | -937.66K | -805.91K | -567.4K | -481.12K | -539.05K | -232.23K | -242.65K | -1.03M | -1.27M | -1.6M | 364.51K | 10.27K |
| Shares Outstanding (Basic) | 4.9M | 3.54M | 3.03M | 1.49M | 676.96K | 102.72K | 13.2K | 110.27K | 5.53K | 132.03K | 114.71K | 91.53K | 66.74K | 39.49K | 19.69K | 18.6K | 18.23K | 14.7K | 11.67K | 9.69K | 7.48K | 5.99K | 5.66K | 4.86K | 3.05K | 1.66K | 1.35K |
| Shares Outstanding (Diluted) | 4.9M | 3.54M | 3.03M | 1.49M | 676.96K | 102.72K | 13.2K | 110.27K | 5.53K | 132.03K | 114.71K | 91.53K | 66.74K | 39.49K | 19.69K | 18.6K | 18.23K | 14.7K | 11.67K | 9.69K | 7.48K | 5.99K | 5.66K | 4.86K | 3.05K | 1.66K | 1.35K |
| EPS (Basic) | -7.73 | -21.48 | -22.29 | -12.88 | -74.43 | -89.97 | 24.32 | -67.41 | -3.44K | -165 | -147.66 | -347.13 | -271.44 | -747.22 | -1.63K | -278.08 | -482.15 | -547.23 | -1.32K | -1.76K | -2.3K | -4.62K | -2.86K | -1.82K | -819.94 | -2.88K | -2.86K |
| EPS (Diluted) | -7.73 | -21.48 | -22.29 | -12.88 | -74.43 | -89.97 | 24.32 | -67.41 | -3.44K | -165 | -147.66 | -347.13 | -271.44 | -747.22 | -1.63K | -278.08 | -482.15 | -547.23 | -1.32K | -1.76K | -2.3K | -4.62K | -2.86K | -1.82K | -819.94 | -2.88K | -2.86K |
| EBITDA | -37.75M | -73.47M | n/a | n/a | -29.33M | -3.14M | -10.56M | -6.11M | -17.83M | -21.97M | -15.07M | -24.52M | -17.14M | -19.98M | -3.4M | -4.62M | -8.36M | -7.96M | -14.43M | -16.14M | -12.98M | -26.49M | -16.68M | -9.84M | -4M | -4.07M | -3.82M |
| Depreciation & Amortization | 57K | 53K | 61.67M | 18.76M | 41K | 41K | 117K | 106K | 300K | 170K | 77K | 203K | 602.33K | 989.24K | 387.71K | 486.42K | 1.03M | 1.17M | 1.27M | 996.04K | 1.25M | 1.07M | 527.01K | 257.15K | 100K | 341.22K | 31.68K |